Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer
- 12 March 2020
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 43 (3) , 409-420
Abstract
Purpose DCBLD2 expression dysregulation has been reported in several types of human cancer. As yet, however, the role of DCBLD2 in colorectal cancer (CRC) is not known. Methods CRC tissues were obtained from patients undergoing surgery from February 2009 to May 2014 (n = 90). Tissue microarray construction and immunohistochemistry were carried out to determine DCBLD2 expression. In vivo studies were performed in 4-week-old BALB/c nude mice. In vitro studies were conducted using CRC-derived HT29 and HCT116 cell lines. Results DCBLD2 expression was found to be significantly increased in CRC tissues compared to adjacent normal tissues (p < 0.001). In addition, we found that DCBLD2 expression was positively correlated with the stage of the disease, the degree of differentiation and vascular invasion. High DCBLD2 expression was significantly associated with a poor overall survival. In vitro, DCBLD2 expression downregulation significantly reduced CRC cell proliferation and invasion. In a mouse xenograft model, DCBLD2 expression downregulation reduced lung metastasis and increased overall survival. Gene set enrichment analysis (GSEA) revealed that DCBLD2 overexpression induces epithelial–mesenchymal transition (EMT) and activates the JAK/STAT3 pathway. Conclusions We found that high DCBLD2 expression correlated with a poor clinical outcome, as well as tumorigenesis, invasion and metastasis of CRC cells. DCBLD2 may serve as a prognostic biomarker and a novel therapeutic target for CRC.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province, China (2018A030313676)
- Guangzhou Planned Project of Science and Technology (201707010275)
- Fundamental Research Funds for the Central Universities (2017ZD104)
- Guangdong Planned Project of Science and Technology (2017B020226001)
This publication has 31 references indexed in Scilit:
- The emerging role of noncoding RNAs in colorectal cancer chemoresistanceCellular Oncology, 2019
- Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosisCellular Oncology, 2019
- Predicting Secretory Proteins with SignalP2017
- Tyrosine phosphorylation of the orphan receptor ESDN/DCBLD2 serves as a scaffold for the signaling adaptor CrkLFEBS Letters, 2013
- A new bioinformatics analysis tools framework at EMBL-EBINucleic Acids Research, 2010
- The epithelial-mesenchymal tansition (EMT) and colorectal cancer progressionCancer Biology & Therapy, 2005
- Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivoOncogene, 2002
- Focus on colon cancerCancer Cell, 2002
- ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular InjuryJournal of Biological Chemistry, 2001
- Phases of Biomarker Development for Early Detection of CancerJNCI: Journal of the National Cancer Institute, 2001